Dinox GmbH
- Address
- lock Available on a paid plan
Reproductive Health and Contraception
At Dinox GmbH in Berlin, clinical research in female urogenital diseases and reproductive physiology includes studies focused on contraceptive effectiveness and the stability of ovulation inhibition when treatment schedules are not followed exactly.
- Maintenance of ovulation suppression after intentional intake or application errors
- Evaluation of contraceptive reliability in healthy subjects
- Research on how delayed or missed use may affect protection
These trials help assess whether new or existing contraceptive approaches can continue to work as intended under real-world use conditions.
Postmenopausal Vaginal Health
Another key area of research at this site is vaginal atrophy in postmenopausal women, with studies examining treatments intended to improve comfort, tissue health, and related symptoms.
- Changes in vaginal tissue appearance and cytologic patterns
- Effects on vaginal pH and local vaginal environment
- Testing treatment benefit for vaginal atrophy and menopausal discomfort
The goal is to better understand how hormonal therapies may support vaginal health and ease symptoms associated with menopause.
Menopause-Related Symptoms and Hair Loss
Clinical trials also explore physiological processes linked to postmenopausal women with vasomotor menopausal symptoms and female pattern hair loss, assessing whether treatment can improve symptom burden and visible hair outcomes.
- Hair growth measures in women with female pattern hair loss
- Safety and tolerability of treatment in postmenopausal participants
- Assessment of effects on the endometrium and bleeding patterns
These studies are designed to evaluate both symptom relief and overall treatment safety, supporting better care options for women after menopause.
Hormonal Treatment Research
The site’s broader research portfolio includes work on reproductive and urinary physiological phenomena, with attention to how hormone-based therapies act in the body and how they may be used to test new treatment options.
- Assessment of systemic exposure to hormonal therapy
- Evaluation of local and overall treatment effects
- Testing new approaches for women’s health conditions
Overall, the studies at Dinox GmbH combine contraception, menopause care, and vaginal health research to improve understanding of women’s health treatments.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 10 by active trials.
No sponsors linked to active trials.
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 2 161 other sites in Germany
Therapeutic Area Benchmark — Germany
Select a therapeutic area to compare against other sites in Germany.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Germany
Market Share
Country: Germany
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Dinox GmbH
lock Showing 1 of 4 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A single-centre, open-label, randomised, phase II study on the maintenance of ovulation inhibition after intentional application errors during 84 days of treatment with MR-130A-01 contraceptive transdermal patch | Mylan Pharmaceuticals Inc. | Phase II | Not Recruiting | Dec 2025 | — |
IMP list
lock Showing 1 of 3 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Estriol | 1 | Unknown | 2025-07-16 | 2025-07-16 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.
